Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
47
2024
380
8.430
 Why?
Multiple Sclerosis, Relapsing-Remitting
14
2024
69
3.170
 Why?
Neurology
10
2018
87
2.540
 Why?
Immunosuppressive Agents
10
2024
674
1.840
 Why?
Immunologic Factors
11
2020
222
1.730
 Why?
Neuromyelitis Optica
4
2023
114
1.270
 Why?
Natalizumab
11
2021
46
1.030
 Why?
Recurrence
7
2024
967
0.800
 Why?
Diagnostic Errors
2
2017
156
0.780
 Why?
Internship and Residency
5
2011
964
0.760
 Why?
Drug Substitution
2
2019
47
0.710
 Why?
Fingolimod Hydrochloride
5
2020
30
0.700
 Why?
Rituximab
4
2020
149
0.660
 Why?
Brain
14
2021
2381
0.650
 Why?
Data Collection
4
2011
641
0.640
 Why?
Dementia, Vascular
3
2009
17
0.640
 Why?
Drug Monitoring
1
2019
185
0.620
 Why?
Early Medical Intervention
1
2017
55
0.580
 Why?
Medication Adherence
2
2019
555
0.570
 Why?
Early Diagnosis
2
2017
221
0.570
 Why?
Glatiramer Acetate
6
2019
20
0.550
 Why?
Physicians
4
2016
781
0.540
 Why?
Antibodies, Monoclonal, Humanized
8
2023
667
0.510
 Why?
Calcinosis
2
2009
256
0.510
 Why?
Postural Balance
3
2018
182
0.510
 Why?
Humans
79
2024
117048
0.500
 Why?
Magnetic Resonance Imaging
23
2023
3121
0.470
 Why?
Fatigue
3
2018
288
0.430
 Why?
Dimethyl Fumarate
3
2020
10
0.400
 Why?
Immunoglobulin G
4
2023
786
0.400
 Why?
Practice Guidelines as Topic
1
2018
1403
0.360
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
25
0.360
 Why?
Withholding Treatment
2
2021
67
0.360
 Why?
Middle Aged
37
2021
27170
0.340
 Why?
Psychiatry
2
2009
154
0.330
 Why?
Cysts
1
2009
94
0.320
 Why?
Adult
41
2023
31003
0.310
 Why?
Demyelinating Diseases
4
2019
76
0.310
 Why?
Education, Medical
1
2011
226
0.310
 Why?
Autoantibodies
3
2023
1332
0.310
 Why?
Certification
1
2008
89
0.300
 Why?
Education
2
2007
101
0.290
 Why?
Clinical Trials as Topic
3
2016
957
0.290
 Why?
Central Nervous System Cysts
1
2006
12
0.290
 Why?
Cerebral Arteries
1
2006
55
0.280
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
43
0.270
 Why?
Single-Blind Method
3
2023
259
0.270
 Why?
Cerebrovascular Disorders
1
2006
83
0.270
 Why?
Societies, Medical
4
2019
684
0.270
 Why?
HIV Long Terminal Repeat
2
1997
7
0.260
 Why?
DNA, Viral
2
1998
349
0.260
 Why?
Treatment Outcome
12
2023
9256
0.260
 Why?
Female
46
2023
60631
0.260
 Why?
Databases, Factual
3
2016
1167
0.250
 Why?
Double-Blind Method
4
2023
1670
0.240
 Why?
Drug Industry
2
2016
104
0.240
 Why?
Male
36
2023
56660
0.240
 Why?
Conflict of Interest
2
2016
120
0.230
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
50
0.220
 Why?
B-Lymphocytes
5
2023
771
0.200
 Why?
Mental Disorders
2
2007
899
0.200
 Why?
Quality of Health Care
2
2017
580
0.200
 Why?
Lymphoma
2
2005
178
0.200
 Why?
Brain Neoplasms
4
2016
1010
0.200
 Why?
Interferon beta-1a
2
2019
12
0.200
 Why?
Central Nervous System Neoplasms
2
2005
127
0.190
 Why?
Neuroimaging
1
2023
251
0.190
 Why?
Education, Medical, Continuing
2
2015
118
0.190
 Why?
Lymphopenia
1
2020
49
0.180
 Why?
Agammaglobulinemia
1
2020
31
0.180
 Why?
Referral and Consultation
1
2005
640
0.180
 Why?
Disease Progression
4
2021
2467
0.180
 Why?
Interferon-gamma
1
2023
732
0.180
 Why?
Serum Sickness
1
2019
7
0.170
 Why?
Neutropenia
1
2020
129
0.170
 Why?
Indans
1
2019
9
0.170
 Why?
Oxadiazoles
1
2019
32
0.170
 Why?
Diagnosis, Differential
4
2023
1341
0.170
 Why?
Adjuvants, Immunologic
3
2015
205
0.160
 Why?
Lymphoma, AIDS-Related
1
1998
13
0.160
 Why?
Educational Measurement
3
2015
268
0.160
 Why?
Salvage Therapy
1
2019
129
0.160
 Why?
Physician-Patient Relations
2
2016
474
0.150
 Why?
Eye Movements
1
2018
52
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
535
0.150
 Why?
Herpesvirus 8, Human
1
1998
64
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
243
0.150
 Why?
AIDS Dementia Complex
1
1997
50
0.150
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.150
 Why?
Central Nervous System
2
2005
241
0.150
 Why?
Patient Selection
2
2015
656
0.150
 Why?
Sarcoma, Kaposi
1
1998
69
0.150
 Why?
Herpesvirus 4, Human
1
2018
123
0.150
 Why?
HIV Seropositivity
1
1998
110
0.150
 Why?
Neurologists
1
2016
18
0.140
 Why?
Young Adult
6
2023
10674
0.140
 Why?
Herpesviridae Infections
1
1998
139
0.140
 Why?
Costs and Cost Analysis
1
2017
200
0.140
 Why?
Cost-Benefit Analysis
2
2016
544
0.140
 Why?
Estriol
1
2015
6
0.140
 Why?
Aged
8
2023
19356
0.130
 Why?
Dizziness
2
2018
70
0.130
 Why?
T-Lymphocytes
1
2023
1769
0.130
 Why?
Verbal Learning
2
2013
62
0.130
 Why?
Corpus Callosum
2
2006
59
0.130
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
86
0.130
 Why?
Follow-Up Studies
6
2020
4507
0.130
 Why?
Trust
1
2016
111
0.120
 Why?
Retrospective Studies
9
2020
12823
0.120
 Why?
Ethics, Medical
1
2015
69
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
38
0.120
 Why?
Exercise Therapy
1
2018
352
0.120
 Why?
Insurance, Health
1
2016
247
0.120
 Why?
Medication Reconciliation
1
2013
25
0.110
 Why?
CD40 Antigens
1
2014
79
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
130
0.110
 Why?
JC Virus
1
2013
23
0.110
 Why?
Anti-Inflammatory Agents
2
2006
456
0.110
 Why?
Population Surveillance
1
2016
406
0.110
 Why?
Sensation Disorders
1
2012
30
0.110
 Why?
Memory Disorders
1
2013
154
0.110
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.110
 Why?
Glioma
1
2016
302
0.110
 Why?
Immunoglobulin Heavy Chains
3
2007
71
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
15
0.100
 Why?
Optic Nerve
2
2005
65
0.100
 Why?
T-Lymphocyte Subsets
1
2014
386
0.100
 Why?
Quality of Life
3
2021
2374
0.100
 Why?
Gadolinium
4
2018
79
0.100
 Why?
Self-Assessment
1
2011
61
0.090
 Why?
Learning
1
2015
362
0.090
 Why?
Academies and Institutes
1
2011
45
0.090
 Why?
Biomarkers
3
2014
3549
0.090
 Why?
Nervous System Diseases
1
2013
254
0.090
 Why?
Nerve Regeneration
1
2010
53
0.090
 Why?
Fatal Outcome
3
2006
281
0.090
 Why?
Diagnostic Tests, Routine
1
2011
89
0.090
 Why?
Antigens, CD19
3
2007
97
0.090
 Why?
Leukocytosis
1
2010
34
0.090
 Why?
Exercise Test
1
2012
541
0.090
 Why?
Cranial Nerve Neoplasms
1
1989
6
0.090
 Why?
Severity of Illness Index
3
2014
2633
0.090
 Why?
Hemangioma, Cavernous
1
1989
16
0.090
 Why?
Optic Chiasm
1
1989
18
0.090
 Why?
Central Nervous System Infections
1
2010
36
0.090
 Why?
Disease Management
1
2013
560
0.090
 Why?
United States
7
2019
12379
0.080
 Why?
Guidelines as Topic
1
2011
250
0.080
 Why?
Spinal Cord
3
2023
353
0.080
 Why?
Neuroprotective Agents
1
2009
106
0.080
 Why?
Physical Therapy Modalities
1
2011
271
0.080
 Why?
Practice Patterns, Physicians'
1
2016
1191
0.080
 Why?
Workload
1
2009
129
0.080
 Why?
Hospital-Physician Relations
1
2007
2
0.080
 Why?
Antibodies, Monoclonal
2
2011
1271
0.070
 Why?
Neuropsychological Tests
2
2013
924
0.070
 Why?
Immunoglobulin Variable Region
2
2004
72
0.070
 Why?
HIV-1
1
1992
771
0.070
 Why?
Headache Disorders
1
2006
12
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
17
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
40
0.070
 Why?
Huntington Disease
1
2007
38
0.070
 Why?
Medical Records
1
2007
159
0.070
 Why?
Glial Fibrillary Acidic Protein
1
2006
85
0.070
 Why?
Syndrome
2
2023
339
0.070
 Why?
International Classification of Diseases
1
2007
117
0.070
 Why?
Methylprednisolone
1
2006
83
0.070
 Why?
Contrast Media
3
2018
372
0.070
 Why?
Antibody Formation
1
2007
275
0.070
 Why?
Intracranial Hemorrhages
1
2006
76
0.070
 Why?
Aquaporin 4
1
2006
87
0.070
 Why?
Herpes Zoster
1
2010
332
0.070
 Why?
Canada
2
2019
337
0.070
 Why?
Fellowships and Scholarships
1
2009
244
0.070
 Why?
Surveys and Questionnaires
4
2016
4661
0.070
 Why?
DNA Mutational Analysis
1
2006
373
0.070
 Why?
Patient Compliance
1
2009
527
0.060
 Why?
RNA, Messenger
1
1992
2632
0.060
 Why?
Health Care Surveys
1
2007
536
0.060
 Why?
Cognition Disorders
1
2009
476
0.060
 Why?
Affect
1
2007
243
0.060
 Why?
Teaching
1
2007
225
0.060
 Why?
Neutrophils
1
2010
1081
0.060
 Why?
Erythrocytes
1
2010
604
0.060
 Why?
Neurologic Examination
1
2005
118
0.060
 Why?
Analysis of Variance
3
2015
1239
0.060
 Why?
Program Evaluation
1
2009
827
0.060
 Why?
Central Nervous System Diseases
1
2005
63
0.060
 Why?
Simvastatin
1
2004
61
0.060
 Why?
Faculty, Medical
1
2006
236
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.060
 Why?
Proteoglycans
1
2004
109
0.060
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
36
0.060
 Why?
Adolescent
7
2021
18213
0.060
 Why?
B-Lymphocyte Subsets
1
2003
67
0.050
 Why?
Cyclophosphamide
1
2003
218
0.050
 Why?
Anticoagulants
1
2006
542
0.050
 Why?
Academic Medical Centers
1
2005
415
0.050
 Why?
Dementia
1
2005
179
0.050
 Why?
Radiography
1
2005
843
0.050
 Why?
Cross-Sectional Studies
1
2012
4510
0.050
 Why?
Students, Medical
1
2006
284
0.050
 Why?
Infusions, Intravenous
1
2023
376
0.050
 Why?
Membrane Glycoproteins
1
2004
439
0.050
 Why?
Patient Outcome Assessment
1
2023
121
0.050
 Why?
Lymphoma, B-Cell
2
2005
83
0.050
 Why?
Clinical Competence
1
2008
920
0.050
 Why?
Peptides
3
2013
868
0.050
 Why?
Pain
1
2007
719
0.050
 Why?
Time Factors
4
2018
6240
0.050
 Why?
Schools, Medical
1
2002
124
0.050
 Why?
Disability Evaluation
2
2014
274
0.050
 Why?
Antibodies, Antinuclear
1
2001
56
0.050
 Why?
Atrophy
1
2021
157
0.050
 Why?
Consensus
1
2023
532
0.050
 Why?
Molecular Sequence Data
3
2004
2817
0.050
 Why?
Child
5
2016
18876
0.050
 Why?
Mobility Limitation
1
2020
62
0.040
 Why?
Antibodies, Viral
1
2023
532
0.040
 Why?
Interferon-beta
2
2011
82
0.040
 Why?
Lipids
1
2023
584
0.040
 Why?
Lymphocyte Activation
1
2003
1063
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
58
0.040
 Why?
Cerebral Infarction
1
1998
39
0.040
 Why?
Cell Separation
2
2014
293
0.040
 Why?
Transplantation, Autologous
1
2019
190
0.040
 Why?
HIV Seronegativity
1
1998
24
0.040
 Why?
Genes, myc
1
1998
46
0.040
 Why?
Astrocytoma
1
1998
110
0.040
 Why?
In Situ Hybridization
1
2018
301
0.040
 Why?
Risk Assessment
1
2006
3021
0.040
 Why?
Gene Library
1
1997
124
0.040
 Why?
Gene Rearrangement
1
1998
140
0.040
 Why?
Breast Neoplasms
1
2008
1883
0.040
 Why?
Real-Time Polymerase Chain Reaction
1
2018
331
0.040
 Why?
Syndecan-1
2
2007
29
0.030
 Why?
Flow Cytometry
2
2014
1063
0.030
 Why?
Viral Load
1
2018
406
0.030
 Why?
Mutation
1
2006
3420
0.030
 Why?
Drug Administration Schedule
1
2018
723
0.030
 Why?
Colorado
1
2005
4120
0.030
 Why?
Child, Preschool
3
2016
9322
0.030
 Why?
Polymerase Chain Reaction
1
1998
1001
0.030
 Why?
Survival Analysis
1
2018
1240
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1180
0.030
 Why?
Sequence Analysis, DNA
1
1997
741
0.030
 Why?
Patient Care Team
1
2019
520
0.030
 Why?
Incidence
1
2020
2377
0.030
 Why?
Base Sequence
1
1997
2123
0.030
 Why?
Congresses as Topic
1
2015
204
0.030
 Why?
Propylene Glycols
1
2013
26
0.030
 Why?
Ocular Physiological Phenomena
1
1992
11
0.030
 Why?
Sphingosine
1
2013
32
0.030
 Why?
HLA-DR Antigens
1
2014
223
0.030
 Why?
beta-Galactosidase
1
1992
64
0.030
 Why?
Quality-Adjusted Life Years
1
2013
103
0.030
 Why?
Markov Chains
1
2013
118
0.030
 Why?
Drug Therapy, Combination
1
2015
965
0.030
 Why?
Mice, Inbred DBA
1
1992
172
0.030
 Why?
Mice
2
2023
15309
0.030
 Why?
Haplotypes
1
2014
472
0.030
 Why?
Mental Recall
1
2013
174
0.030
 Why?
Animals
3
2023
32737
0.030
 Why?
Comparative Effectiveness Research
1
2013
131
0.030
 Why?
Organ Specificity
1
1992
270
0.030
 Why?
Reference Values
1
2013
750
0.030
 Why?
Depression
2
2011
1137
0.030
 Why?
CD3 Complex
1
2012
93
0.030
 Why?
Intestine, Small
1
1992
129
0.030
 Why?
Ki-67 Antigen
1
2012
105
0.030
 Why?
Thymus Gland
1
1992
298
0.020
 Why?
Mitoxantrone
1
2011
12
0.020
 Why?
Hematologic Tests
1
2011
24
0.020
 Why?
Patient Participation
1
2015
367
0.020
 Why?
Muscle Stretching Exercises
1
2011
17
0.020
 Why?
Clinical Laboratory Techniques
1
2011
88
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1233
0.020
 Why?
Aged, 80 and over
2
2016
6453
0.020
 Why?
Physical Endurance
1
2011
225
0.020
 Why?
Recombinant Fusion Proteins
1
1992
646
0.020
 Why?
Amino Acid Sequence
2
2004
2032
0.020
 Why?
Prevalence
1
2016
2300
0.020
 Why?
Acyclovir
1
2010
100
0.020
 Why?
Respiratory Function Tests
1
2011
523
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
308
0.020
 Why?
History, 19th Century
1
2009
59
0.020
 Why?
Pilot Projects
2
2004
1394
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
53
0.020
 Why?
Injections
1
2009
161
0.020
 Why?
History, 21st Century
1
2009
167
0.020
 Why?
Electrocardiography
1
2011
548
0.020
 Why?
Autoimmunity
1
2014
829
0.020
 Why?
History, 20th Century
1
2009
277
0.020
 Why?
Age of Onset
1
2009
456
0.020
 Why?
Mice, Transgenic
1
1992
1993
0.020
 Why?
Memory
1
2009
211
0.020
 Why?
Gene Expression
1
1992
1466
0.020
 Why?
Walking
1
2011
420
0.020
 Why?
Health
1
2007
79
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
695
0.020
 Why?
Prognosis
2
2006
3390
0.020
 Why?
Association Learning
1
2007
60
0.020
 Why?
Cerebral Ventricles
1
2006
47
0.020
 Why?
Motor Skills
1
2007
82
0.020
 Why?
Hospitalization
1
2015
1762
0.020
 Why?
Herpesvirus 3, Human
1
2010
381
0.020
 Why?
Phenotype
1
2014
2891
0.020
 Why?
Immunologic Memory
1
2007
313
0.020
 Why?
Social Support
1
2009
524
0.020
 Why?
Hypothalamus
1
2006
152
0.020
 Why?
Genetics
1
2005
28
0.020
 Why?
Neurosciences
1
2005
21
0.020
 Why?
Models, Theoretical
1
2009
534
0.020
 Why?
Image Interpretation, Computer-Assisted
1
2006
218
0.020
 Why?
Syndecans
1
2004
5
0.020
 Why?
Clinical Protocols
1
2006
232
0.020
 Why?
Internet
1
2009
594
0.020
 Why?
Anisotropy
1
2004
63
0.020
 Why?
Antiviral Agents
1
2010
655
0.010
 Why?
Plasma Cells
1
2004
57
0.010
 Why?
Risk Factors
2
2008
8873
0.010
 Why?
Immune System
1
2005
178
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Infrared Rays
1
2003
22
0.010
 Why?
Videotape Recording
1
2003
31
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
93
0.010
 Why?
Feasibility Studies
1
2006
750
0.010
 Why?
Saccades
1
2003
35
0.010
 Why?
Antilymphocyte Serum
1
2003
66
0.010
 Why?
Oligoclonal Bands
1
2003
21
0.010
 Why?
Astrocytes
1
2005
172
0.010
 Why?
Antigens, CD34
1
2003
98
0.010
 Why?
Mice, Inbred C57BL
1
1992
4839
0.010
 Why?
Clone Cells
1
2003
247
0.010
 Why?
Whole-Body Irradiation
1
2003
72
0.010
 Why?
Microglia
1
2005
207
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
102
0.010
 Why?
Immunoglobulins
1
2003
149
0.010
 Why?
Observer Variation
1
2003
307
0.010
 Why?
Longitudinal Studies
1
2009
2480
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2403
0.010
 Why?
Sex Characteristics
1
2007
648
0.010
 Why?
Administration, Oral
1
2004
744
0.010
 Why?
Age Factors
1
2009
2950
0.010
 Why?
Infant
1
2015
8121
0.010
 Why?
Urinary Tract Infections
1
2003
134
0.010
 Why?
Biopsy
1
2005
1056
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
18
0.010
 Why?
Predictive Value of Tests
1
2006
1824
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
965
0.010
 Why?
Cohort Studies
1
2011
5050
0.010
 Why?
Cytomegalovirus Infections
1
2003
182
0.010
 Why?
Acute Disease
1
2003
916
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
69
0.010
 Why?
Lung
1
1992
3588
0.010
 Why?
Research
1
2003
402
0.010
 Why?
Combined Modality Therapy
1
2003
1144
0.010
 Why?
Survival Rate
1
2003
1679
0.010
 Why?
Arachnoid
1
1998
10
0.010
 Why?
Sensitivity and Specificity
1
2003
1740
0.010
 Why?
Models, Biological
1
2005
1689
0.010
 Why?
Case-Control Studies
1
2004
3099
0.010
 Why?
Aging
1
2007
1653
0.010
 Why?
Reproducibility of Results
1
2003
2818
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)